{"transactions":[{"id":879448,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:32.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39011,"derivative":{"exercise_price":17.8625,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39011},"source":{"system":"sec-edgar","filing":"0001999371-26-004389","document":"morris-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004389/morris-form4_022626.xml","form_type":"4"}},{"id":879447,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2026-02-26T12:03:32.000Z","date":"2026-02-24","kind":"grant","planned":false,"acquired":true,"shares":39012,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/48th each month thereafter for 36 months."}],"balance_after":39012,"derivative":{"exercise_price":14.29,"exercise_date":"2027-02-24","expiration_date":"2036-02-24","underlying":"Common Stock","underlying_shares":39012},"source":{"system":"sec-edgar","filing":"0001999371-26-004389","document":"morris-form4_022626.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937126004389/morris-form4_022626.xml","form_type":"4"}},{"id":1240533,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:44:51.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29291,"derivative":{"exercise_price":10.0625,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29291},"source":{"system":"sec-edgar","filing":"0001839882-25-011949","document":"morris_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011949/morris_form4-022725.xml","form_type":"4"}},{"id":1240532,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2025-02-27T23:44:51.000Z","date":"2025-02-25","kind":"grant","planned":false,"acquired":true,"shares":29291,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":29291,"derivative":{"exercise_price":8.05,"exercise_date":"2026-02-25","expiration_date":"2035-02-25","underlying":"Common Stock","underlying_shares":29291},"source":{"system":"sec-edgar","filing":"0001839882-25-011949","document":"morris_form4-022725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011949/morris_form4-022725.xml","form_type":"4"}},{"id":1240531,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2025-02-27T23:44:51.000Z","date":"2025-02-05","kind":"other","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares were surrendered without considerations following a reverse stock split of the Issuer's common stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001839882-25-011949","document":"morris_form4-022725.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988225011949/morris_form4-022725.xml","form_type":"4"}},{"id":1609851,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:06:23.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":317000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":317000,"derivative":{"exercise_price":0.46,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":317000},"source":{"system":"sec-edgar","filing":"0001999371-24-002950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002950/ownership.xml","form_type":"4"}},{"id":1609850,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2024-02-29T22:06:23.000Z","date":"2024-02-27","kind":"grant","planned":false,"acquired":true,"shares":317000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":317000,"derivative":{"exercise_price":0.368,"exercise_date":"2025-02-27","expiration_date":"2034-02-27","underlying":"Common Stock","underlying_shares":317000},"source":{"system":"sec-edgar","filing":"0001999371-24-002950","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000199937124002950/ownership.xml","form_type":"4"}},{"id":1992992,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:36:51.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":207500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":207500,"derivative":{"exercise_price":0.914,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":207500},"source":{"system":"sec-edgar","filing":"0001839882-23-004702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004702/ownership.xml","form_type":"4"}},{"id":1992991,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2023-02-24T23:36:51.000Z","date":"2023-02-23","kind":"grant","acquired":true,"shares":207500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":207500,"derivative":{"exercise_price":0.731,"exercise_date":"2024-02-23","expiration_date":"2033-02-23","underlying":"Common Stock","underlying_shares":207500},"source":{"system":"sec-edgar","filing":"0001839882-23-004702","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000183988223004702/ownership.xml","form_type":"4"}},{"id":2388192,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:18:20.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":1100000,"derivative":{"exercise_price":0.828,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001387131-22-002106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002106/ownership.xml","form_type":"4"}},{"id":2388191,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:18:20.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":1100000,"derivative":{"exercise_price":0.621,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001387131-22-002106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002106/ownership.xml","form_type":"4"}},{"id":2388190,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:18:20.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"10% of the option vests on the first anniversary of issuance, 10% on the second anniversary of issuance, 40% on the third anniversary of issuance, and 40% on the fourth anniversary of issuance."}],"balance_after":1100000,"derivative":{"exercise_price":0.414,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001387131-22-002106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002106/ownership.xml","form_type":"4"}},{"id":2388189,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2022-02-17T22:18:20.000Z","date":"2022-02-15","kind":"grant","acquired":true,"shares":1100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":1100000,"derivative":{"exercise_price":0.207,"exercise_date":"2023-02-15","expiration_date":"2032-02-15","underlying":"Common Stock","underlying_shares":1100000},"source":{"system":"sec-edgar","filing":"0001387131-22-002106","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713122002106/ownership.xml","form_type":"4"}},{"id":2832439,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2021-02-25T22:49:05.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":540000,"derivative":{"exercise_price":1.53,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":540000},"source":{"system":"sec-edgar","filing":"0001387131-21-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121002886/ownership.xml","form_type":"4"}},{"id":2832438,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2021-02-25T22:49:05.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":540000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One-third of the option vests on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":540000,"derivative":{"exercise_price":1.22,"exercise_date":"2022-02-23","expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":540000},"source":{"system":"sec-edgar","filing":"0001387131-21-002886","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713121002886/ownership.xml","form_type":"4"}},{"id":3159349,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2020-05-06T22:29:10.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":360000,"derivative":{"exercise_price":0.96,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001387131-20-004487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004487/ownership.xml","form_type":"4"}},{"id":3159348,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2020-05-06T22:29:10.000Z","date":"2020-05-04","kind":"grant","acquired":true,"shares":360000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's Amended and Restated 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":360000,"derivative":{"exercise_price":0.77,"exercise_date":"2021-05-04","expiration_date":"2030-05-04","underlying":"Common Stock","underlying_shares":360000},"source":{"system":"sec-edgar","filing":"0001387131-20-004487","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120004487/ownership.xml","form_type":"4"}},{"id":3243768,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2020-02-27T21:20:58.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":24000,"derivative":{"exercise_price":0.5,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001387131-20-002251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120002251/ownership.xml","form_type":"4"}},{"id":3243767,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2020-02-27T21:20:58.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2020 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":24000,"derivative":{"exercise_price":0.4,"exercise_date":"2021-02-25","expiration_date":"2030-02-25","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001387131-20-002251","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713120002251/ownership.xml","form_type":"4"}},{"id":3535095,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2019-05-08T12:00:22.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":28835,"derivative":{"exercise_price":2.56,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":28835},"source":{"system":"sec-edgar","filing":"0001387131-19-003425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003425/ownership.xml","form_type":"4"}},{"id":3535094,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2019-05-08T12:00:22.000Z","date":"2019-05-06","kind":"grant","acquired":true,"shares":28835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2019 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":28835,"derivative":{"exercise_price":2.05,"exercise_date":"2020-05-06","expiration_date":"2029-05-06","underlying":"Common Stock","underlying_shares":28835},"source":{"system":"sec-edgar","filing":"0001387131-19-003425","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119003425/ownership.xml","form_type":"4"}},{"id":3628859,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-27T22:37:20.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":5170,"derivative":{"exercise_price":2.36,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":5170},"source":{"system":"sec-edgar","filing":"0001387131-19-001535","document":"morris-form4_022719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119001535/morris-form4_022719.xml","form_type":"4"}},{"id":3628858,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock","published_at":"2019-02-27T22:37:20.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":5170,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2018 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":5170,"derivative":{"exercise_price":1.89,"exercise_date":"2020-02-26","expiration_date":"2029-02-25","underlying":"Common Stock","underlying_shares":5170},"source":{"system":"sec-edgar","filing":"0001387131-19-001535","document":"morris-form4_022719.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000138713119001535/morris-form4_022719.xml","form_type":"4"}},{"id":3893717,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Common Stock, $0.001 par value","published_at":"2018-06-14T20:05:22.000Z","date":"2018-06-14","kind":"purchase","acquired":true,"shares":300,"price":4.19,"value":1257.0,"ownership":{"direct":true},"balance_after":1638,"source":{"system":"sec-edgar","filing":"0001615774-18-005288","document":"s110837_form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418005288/s110837_form4.xml","form_type":"4"}},{"id":4054657,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2018-02-15T21:08:06.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":39150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":39150,"derivative":{"exercise_price":4.25,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":39150},"source":{"system":"sec-edgar","filing":"0001615774-18-001261","document":"s109084_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001261/s109084_form4.xml","form_type":"4"}},{"id":4054656,"issuer":{"id":6169,"kind":"organization","name":"Tonix Pharmaceuticals Holding Corp.","symbol":"TNXP"},"owners":[{"id":64461,"kind":"person","name":"MORRIS JESSICA EDGAR","position":1,"cik":"0001656531","reported_name":"MORRIS JESSICA EDGAR","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Stock Option","published_at":"2018-02-15T21:08:06.000Z","date":"2018-02-13","kind":"grant","acquired":true,"shares":39150,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The option was granted pursuant to the Issuer's 2017 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 1/3rd on the first anniversary of issuance and 1/36th each month thereafter for 24 months."}],"balance_after":39150,"derivative":{"exercise_price":3.4,"exercise_date":"2019-02-13","expiration_date":"2028-02-12","underlying":"Common Stock","underlying_shares":39150},"source":{"system":"sec-edgar","filing":"0001615774-18-001261","document":"s109084_form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1430306/000161577418001261/s109084_form4.xml","form_type":"4"}}]}